Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | ATM | Q13315 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22549651 | 1.00 | HPGD (0.53) | HPGDHSD11B1ALDH1A1ATMCYP1A2 | |
| SCHEMBL13989210 | 1.00 | HPGD (0.53) | HPGDHSD11B1ALDH1A1ATMCYP1A2 | |
| SCHEMBL6662693 | 1.00 | HPGD (0.53) | HPGDHSD11B1ALDH1A1ATMCYP1A2 | |
| SCHEMBL7285687 | 0.98 | HPGD (0.50) | HPGDHSD11B1ALDH1A1ATMCYP1A2 | |
| SCHEMBL10617855 | 0.93 | — | — | |
| SCHEMBL10616701 | 0.87 | — | — | |
| SCHEMBL9668398 | 0.86 | CYP1A2 (0.52) | HPGDHSD11B1CYP1A2SMN1; SMN2EPHX1 | |
| SCHEMBL4990375 | 0.85 | KDM5A (0.50) | HPGDCYP1A2EPHX1 | |
| SCHEMBL6565536 | 0.84 | CYP1A2 (0.48) | HPGDHSD11B1CYP1A2EPHX1 | |
| SCHEMBL7909306 | 0.83 | KDM5A (0.53) | HPGDCYP1A2MEN1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250043211-A1 | 4-CYCLOHEXYLBUTAN-2-ONE AS A FRAGRANCE | SYMRISE AG (DE) | 2025-02-06 | — | — | US | claimed |
| EP-4444838-A1 | 4-CYCLOHEXYLBUTAN-2-ONE AS A FRAGRANCE | Symrise AG (DE) | 2024-10-16 | — | — | EP | claimed |
| CN-118574918-A | 4-Cyclohexylbutan-2-one as a fragrance | 西姆莱斯股份公司 | 2024-08-30 | — | — | CN | claimed |
| WO-2023104308-A1 | 4-CYCLOHEXYLBUTAN-2-ONE AS A FRAGRANCE | SYMRISE AG (DE) | 2023-06-15 | — | — | WO | claimed |
| CN-102580033-B | Medicinal composition for treating skin injury and quality detection method | GUANGXI WUZHOU SANHE PHARMACEUTICAL CO LTD | 2014-05-07 | — | — | CN | claimed |
| CN-102914615-A | Detection method for compound desert cistanche yizhi capsule | LIAOYUAN YULONG YADONG PHARMACEUTICAL CO LTD | 2013-02-06 | — | — | CN | claimed |
| EP-0009540-B1 | FRAGRANCE COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1983-03-02 | — | — | EP | claimed |
| US-4225444-A | Fragrance compositions containing 3-methyl-1-phenyl-pentanol-5 or specific optical isomers thereof and one or more butanoyl cyclohexane derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-09-30 | — | — | US | claimed |
| US-4217253-A | PERFUMES | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-08-12 | — | — | US | claimed |
| US-4210554-A | DETERGENTS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-07-01 | — | — | US | claimed |
| US-4206090-A | PERFUMES | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-06-03 | — | — | US | claimed |
| EP-0009540-A2 | Fragrance compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-04-16 | — | — | EP | claimed |
| US-20260071137-A1 | 5,5-DISUBSTITUED TETRAHYDROFURAN-2-ONE AS FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2026-03-12 | — | — | US | disclosed |
| US-20250326985-A1 | CYCLOHEXANE AND/OR CYCLOHEXENE ESTERS AS A FRAGRANCE | SYMRISE AG (DE) | 2025-10-23 | — | — | US | disclosed |
| EP-4532645-A1 | 5,5-DISUBSTITUED TETRAHYDROFURAN-2-ONE AS FRAGRANCE COMPOUNDS | Symrise AG (DE) | 2025-04-09 | — | — | EP | disclosed |
| EP-4518976-A1 | CYCLOHEXANE AND/OR CYCLOHEXENE ESTERS AS A FRAGRANCE | Symrise AG (DE) | 2025-03-12 | — | — | EP | disclosed |
| CN-1309634-A | Hydrazine derivs. | HOFFMANN LA ROCHE (CH) | 2001-08-22 | — | — | CN | disclosed |
| US-6252118-B1 | REACTING A KETONE HAVING A BETA HYDROGEN WITH AN OLEFIN CATALYZED BY A TRANSITION METAL CATALYST COMPOUND WITH THE AID OF A 2-AMINOPYRIDINE DERIVATIVE | Jun, Chul Ho (KR) | 2001-06-26 | — | — | US | disclosed |
| US-4193934-A | PERFUMES | HAARMANN & REIMER GMBH (DE) | 1980-03-18 | — | — | US | disclosed |
| US-4067886-A | REACTING KETONES AND KETALS WITH HALOGEN | LEVER BROTHERS COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250326985-A1 | CYCLOHEXANE AND/OR CYCLOHEXENE ESTERS AS A FRAGRANCE | CYP51A1, FAAH2, FAAH | HPGD 106/4885HSD11B1 142/4885ALDH1A1 276/4885 |
| US-20260071137-A1 | 5,5-DISUBSTITUED TETRAHYDROFURAN-2-ONE AS FRAGRANCE COMPOUNDS | PRMT5, ACSL5, ELOVL5 | HPGD 342/4885HSD11B1 1929/4885ALDH1A1 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.